EX-10.3
from 10-Q
92 pages
Master Agreement by and Among Msp Technology (U.S.) Company LLC, Msp Singapore Company, LLC, Schering Corporation, Schering-Plough Corporation, and Merck & Co., Inc. Dated as of December 18, 2001
12/34/56
EX-10.1
from 10-Q
56 pages
Cholesterol Governance Agreement by and Among Msp Distribution Services (C) LLC, Msp Marketing Services (C) LLC, Msp Technology (US) Company LLC, Merck Cardiovascular Health Company, Merck Technology (US) Company, Inc., Schering Msp Corporation, Schering Sales Management, Inc., Schering Sales Corporation, Schering Msp Pharmaceuticals L.P., Msp Cholesterol LLC, Msp Singapore Company, LLC, Msd Technology Singapore Pte. Ltd., Msd Ventures Singapore Pte. Ltd., Osammor Pte. Ltd. (To Be Renamed Schering-Plough (Singapore) Pte. Ltd.), Citimere Pte. Ltd. (To Be Renamed Schering-Plough (Singapore) Research Pte. Ltd.), Schering Corporation, Schering-Plough Corporation, and Merck & Co., Inc. Dated as of May 22, 2000
12/34/56